Amount Raised
$16.8 Million
Round Type
Series A
Investors
Description
Pelage Pharmaceuticals raised $16.75M in Series A funding led by GV with participation from Main Street Advisors, Visionary Ventures, and YK BioVentures. The company plans to use the funds to advance a first-in-class treatment for androgenetic alopecia, pattern baldness, and other types of alopecia, including chemotherapy-induced hair loss.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Pelage Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- RenovoRx raised $11M on April 11, 2024.
- BioLineRx Ltd raised $20M (Pre-Seed) on April 10, 2024.
- Enlaza Therapeutics raised $84M on April 5, 2024.
- Corvex Legacy Holdings raised $24M (Seed) on April 2, 2024.
- Pierrepont Therapeutics raised $2.1M (Seed) on April 2, 2024.
- Corvex Legacy Holdings raised $24M on April 2, 2024.
Who to call at Pelage Pharmaceuticals, and when
A new round usually means Pelage Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pelage Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pelage Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pelage Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pelage Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPelage Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.